FDA delays decision on first drug to prevent HIV infection
London: US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.
Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.
In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.
The group’s vote is non-binding, but the FDA often follows its advice.
Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.
The FDA typically extends its reviews after receiving such information.
More from India
More from World
More from Sports
More from Entertaiment
- 24 dead after boat carrying 40 capsizes in river Ganga in Patna; many still missing
- Dr Subhash Chandra Show: What characteristics define a true leader?
- My father wanted me to be a man of character: Navjot Singh Siddhu
- Tourists flock to Manali as snowfall takes a short break
- Is Akhilesh Yadav overlooking Muslims as Mulayam Singh alleged?
- Abhishek Bachchan reveals the moment when Aishwarya Rai said 'yes' to him
- India vs England, 1st ODI: As it happened...
- India vs England, Pune ODI: MS Dhoni still the boss; convinces Virat Kohli with spot on DRS call — WATCH
- India vs England, 1st ODI: Ravichandran Aswhin steals the show with huge six — WATCH
- Petrol price hiked by 42 paisa per litre, diesel by Rs 1.03 a litre